This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Feb 15;21(4):577-9.

doi: 10.1200/JCO.2003.10.086.

Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?

Andrew D Seidman

PMID: 12586789
DOI: 10.1200/JCO.2003.10.086

Review

Sequential single-agent chemotherapy for metastatic breast cancer: therapeutic nihilism or realism?

Andrew D Seidman. J Clin Oncol. 2003.

. 2003 Feb 15;21(4):577-9.

doi: 10.1200/JCO.2003.10.086.

Author

Andrew D Seidman

PMID: 12586789
DOI: 10.1200/JCO.2003.10.086

No abstract available

PubMed Disclaimer

Comment on

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC. Sledge GW, et al. J Clin Oncol. 2003 Feb 15;21(4):588-92. doi: 10.1200/JCO.2003.08.013. J Clin Oncol. 2003. PMID: 12586793 Clinical Trial.

Similar articles

Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Köstler WJ, Brodowicz T, Zielinski CC; Central European Cooperative Oncology Group (CECOG). Köstler WJ, et al. J Natl Cancer Inst. 2010 Feb 3;102(3):207; author reply 207-8. doi: 10.1093/jnci/djp483. Epub 2010 Jan 6. J Natl Cancer Inst. 2010. PMID: 20054016 No abstract available.
Improved outcomes from dose-dense adjuvant chemotherapy for breast cancer with growth factor support.
Leonard JP. Leonard JP. Curr Hematol Rep. 2003 Nov;2(6):451-2. Curr Hematol Rep. 2003. PMID: 14561387 Clinical Trial. No abstract available.
[Chemotherapy of cancer of the breast in the metastatic phase].
Clavel M, Biron P, Chauvin F, Guastalla JP, Rebattu P, el Foudeh M. Clavel M, et al. Bull Cancer. 1989;76(1):75-85. Bull Cancer. 1989. PMID: 2653473 Review. French.
[Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice].
Campone M, Fumoleau P. Campone M, et al. Bull Cancer. 2002 Mar;89(3):275-82. Bull Cancer. 2002. PMID: 11940467 Review. French.
Combination chemotherapy for metastatic breast cancer: reaching for the cure.
Overmoyer B. Overmoyer B. J Clin Oncol. 2003 Feb 15;21(4):580-2. doi: 10.1200/JCO.2003.10.085. J Clin Oncol. 2003. PMID: 12586790 Review. No abstract available.

See all similar articles

Cited by

Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.
Wang H, Venkatesh M, Li H, Goetz R, Mukherjee S, Biswas A, Zhu L, Kaubisch A, Wang L, Pullman J, Whitney K, Kuro-o M, Roig AI, Shay JW, Mohammadi M, Mani S. Wang H, et al. J Clin Invest. 2011 Aug;121(8):3220-32. doi: 10.1172/JCI41514. Epub 2011 Jul 11. J Clin Invest. 2011. PMID: 21747170 Free PMC article.
Single agent versus combination chemotherapy for metastatic breast cancer.
Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, Wilcken N. Carrick S, et al. Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3. Cochrane Database Syst Rev. 2009. PMID: 19370586 Free PMC article.
TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy.
Luo Y, Qiao B, Zhang P, Yang C, Cao J, Yuan X, Ran H, Wang Z, Hao L, Cao Y, Ren J, Zhou Z. Luo Y, et al. Theranostics. 2020 May 25;10(15):6987-7001. doi: 10.7150/thno.44569. eCollection 2020. Theranostics. 2020. PMID: 32550917 Free PMC article.
Role of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials.
Zheng R, Han S, Duan C, Chen K, You Z, Jia J, Lin S, Liang L, Liu A, Long H, Wang S. Zheng R, et al. Medicine (Baltimore). 2015 May;94(17):e803. doi: 10.1097/MD.0000000000000803. Medicine (Baltimore). 2015. PMID: 25929935 Free PMC article.
A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer.
Zeichner SB, Terawaki H, Gogineni K. Zeichner SB, et al. Breast Cancer (Auckl). 2016 Mar 22;10:25-36. doi: 10.4137/BCBCR.S32783. eCollection 2016. Breast Cancer (Auckl). 2016. PMID: 27042088 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information